NCT06798064No Longer Available不适用
Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject
Mya Schiess1 个研究点 分布在 1 个国家开始时间: 2025年1月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 发起方
- 试验地点
- 1
研究概览
简要总结
This is a expanded access use of allogeneic bone marrow-derived mesenchymal stem cells for a single subject with moderate Parkinson's disease that has progressed.
研究设计
- 研究类型
- Expanded Access
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
Mya Schiess
Professor
The University of Texas Health Science Center, Houston
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's DiseaseCrohn's DiseaseFistulaNCT01144962Leiden University Medical Center21
No Longer Available
不适用
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)Acute Ischemic StrokeMesenchymal Stem CellsStroke, AcuteStroke/Brain AttackStroke, IschemicNCT05522569University of Miami
撤回
1 期
Stem Cells for the Treatment of PouchitisUlcerative Colitis ChronicInflammatory Bowel DiseasesPouch, IlealCrohn's DiseasePouchitisNCT05578508The Cleveland Clinic
已完成
不适用
Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients with Refractory Perianal Crohn*s DiseasefistulaM. Crohn10017969NL-OMON36386eids Universitair Medisch Centrum21
进行中（未招募）
不适用
Allogeneic Bone Marrow Derived Mesenchymal Stem Cellsfor the Treatment of Fistulas in Patients withRefractory Perianal Crohn’s Disease - allo bmMSCs CD fistulaEUCTR2009-015680-14-NLeiden University Medical Center